D SEED THERAPEUTICS
LIVE

Serial Number

99361665

Owner

SEED Therapeutics US, Inc.

Attorney

Ian W. Gillies

Filing Date

Aug 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

D SEED THERAPEUTICS Trademark

Serial Number: 99361665

D SEED THERAPEUTICS is a trademark filed by SEED Therapeutics US, Inc. on August 27, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

SEED Therapeutics US, Inc. (4 trademarks)

411 Swedeland Road
King of Prussia, PA 19406

Entity Type: 03

Trademark Details

Filing Date

August 27, 2025

Registration Date

Not Registered

Published for Opposition

June 16, 2026

Goods & Services

Drug discovery and pharmaceutical drug development; Drug validation services, namely, scientifically demonstrating that a new molecular entity has the potential to achieve, or achieves an acceptable balance of benefit to the patients versus side effects; Pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical research and medical research information about pharmaceutical drug development via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology research, and design, planning, and implementation of clinical trials; research and development of new products; scientific, research and development services; medical research services; Providing information about medical and scientific research relating to the identification of ubiquitin ligases for the purposes of degrading a disease-causing protein; scientific consultancy services in the field of identifying ubiquitin ligases for the purposes of degrading a disease-causing protein; Providing information about medical and scientific research with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell; scientific consultancy services in the field of using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 21, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
May 21, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
May 21, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 21, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 24, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 20, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 20, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 21, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 21, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 20, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 16, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 27, 2025 MAFR
NEW APPLICATION ENTERED
Aug 27, 2025 NWAP